June 16, 2021

Diverted Nonprescription Insulin Can Be Dangerous
for Patients

The National Association of Boards of Pharmacy is warning pharmacists about schemes to purchase large amounts of nonprescription insulin and sell it to patients through mail-order suppliers at a higher price. Find out why the group is worried about the safety and potency of the products and what it advises pharmacists to do to protect patients.


COVID-19 Not Very Deadly in Youths but Has Worse Symptoms Than Flu

Pharmacists, like everyone else, have heard naysayers proclaim it countless times: COVID-19 is no worse than the flu. Now, a large, new global study proves that simply isn’t true, finding that children and adolescents had far more symptoms and complications with SARS-CoV-2 infection than influenza. Here is more information.

FDA Grants Accelerated Approval for Controversial Novel Alzheimer’s Drug

In an unusual, accelerated approval, the FDA is requiring the manufacturer of a new Alzheimer’s drug to conduct another clinical trial, with the possibility of withdrawing its okay if the product doesn’t prove clinical benefit. The medication, aducanumab, marketed as Aduhelm, is the first to be approved for the condition in about 18 years and is the first to target the fundamental pathophysiology of the disease. Here is more information.


Antibiotic Use Linked to Reduced Effectiveness for Common NSCLC Therapy

Pharmacists might want to question antibiotic prescriptions for non-small cell lung cancer (NSCLC) patients who are undergoing treatment with immune checkpoint inhibitors (ICI). A new study suggests that anti-infectives can alter the anticancer immune response and reduce ICI efficacy. Here are more details.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -